These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6714294)

  • 21. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR
    N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of transdermal clonidine in the hypertensive patient with chronic renal failure.
    Lowenthal DT; Saris SD; Paran E; Cristal N
    Clin Nephrol; 1993 Jan; 39(1):37-43. PubMed ID: 8428406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of transcutaneous clonidine hydrochloride in the patient with diabetes mellitus and mild hypertension.
    Wallin JD; Krane NK; Bergman S; Morgan M
    J Clin Hypertens; 1985 Dec; 1(4):315-21. PubMed ID: 3836300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance].
    Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of clonidine.
    Lowenthal DT; Matzek KM; MacGregor TR
    Clin Pharmacokinet; 1988 May; 14(5):287-310. PubMed ID: 3293868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal clonidine application: long-term results in essential hypertension.
    Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
    Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alinidine pharmacokinetics following acute and chronic dosing.
    Harron DW; Arndts D; Shanks RG
    Br J Clin Pharmacol; 1982 Jun; 13(6):821-7. PubMed ID: 7093113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period.
    Segal IS; Jarvis DJ; Duncan SR; White PF; Maze M
    Anesthesiology; 1991 Feb; 74(2):220-5. PubMed ID: 1990896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of clonidine on prolonged postoperative sympathetic response.
    Dorman T; Clarkson K; Rosenfeld BA; Shanholtz C; Lipsett PA; Breslow MJ
    Crit Care Med; 1997 Jul; 25(7):1147-52. PubMed ID: 9233740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin pretreatment and the use of transdermal clonidine.
    Ito MK; O'Connor DT
    Am J Med; 1991 Jul; 91(1A):42S-49S. PubMed ID: 1831005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
    Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
    Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.
    Frisk-Holmberg M; Edlund PO; Paalzow L
    Br J Clin Pharmacol; 1978 Sep; 6(3):227-32. PubMed ID: 687501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonidine through the skin in the treatment of essential hypertension: is it practical?
    Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
    J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of oral sustained release clonidine in humans.
    MacGregor TR; Relihan GL; Keirns JJ
    Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose.
    Klein C; Morton N; Kelley S; Metz S
    J Hypertens Suppl; 1985 Dec; 3(4):S81-4. PubMed ID: 3868715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Systemic and Local Pharmacokinetics of Clonidine Mucoadhesive Buccal Tablets with Reference Clonidine Oral Tablets in Healthy Volunteers: An Open-Label Randomised Cross-Over Trial.
    Vasseur B; Dufour A; Houdas L; Goodwin H; Harries K; Emul NY; Hutchings S
    Adv Ther; 2017 Aug; 34(8):2022-2032. PubMed ID: 28726169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Langley MS; Heel RC
    Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New aspects of the clinical pharmacology of clonidine.
    Arndts D
    Chest; 1983 Feb; 83(2 Suppl):397-400. PubMed ID: 6822136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of application site of a new transdermal clonidine, M-5041T, on its pharmacokinetics and pharmacodynamics in healthy subjects.
    Ebihara A; Fujimura A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1993 Dec; 33(12):1188-91. PubMed ID: 8126253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate and extent of absorption of clonidine from a transdermal therapeutic system.
    Toon S; Hopkins KJ; Aarons L; Rowland M
    J Pharm Pharmacol; 1989 Jan; 41(1):17-21. PubMed ID: 2565958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.